Valuation: FDC Limited

Market Cap 58.07B 612M 544M 504M 459M 866M 879M 6.06B 2.38B 30.31B 2.3B 2.25B 96.61B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 53.01B 559M 497M 460M 419M 790M 803M 5.53B 2.17B 27.66B 2.1B 2.05B 88.19B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day+1.55%
1 week+8.06%
Current month+4.99%
1 month+1.64%
3 months-15.01%
6 months-0.54%
Current year-15.73%
1 week 327.05
Extreme 327.05
364.2
1 month 321.5
Extreme 321.5
365
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
473.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 48 31/12/2001
Director/Board Member 63 30/09/1993
Chairman 90 31/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.55%+8.06%-18.45%-7.34% 612M
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.00%+4.06%+29.12%+54.39% 394.15B
Weighted average by Cap. +0.13%+3.83%+39.33%+71.81%

Financials

2025 2026
Net sales 21.08B 222M 197M 183M 167M 314M 319M 2.2B 862M 11B 834M 816M 35.07B 21.71B 229M 203M 188M 171M 324M 329M 2.27B 888M 11.33B 858M 840M 36.11B
Net income 2.67B 28.11M 24.99M 23.16M 21.07M 39.76M 40.4M 278M 109M 1.39B 105M 103M 4.44B 2.81B 29.65M 26.36M 24.43M 22.23M 41.94M 42.62M 294M 115M 1.47B 111M 109M 4.68B
Net Debt -5.15B -54.26M -48.23M -44.7M -40.67M -76.75M -77.98M -537M -211M -2.69B -204M -199M -8.57B -5.06B -53.32M -47.4M -43.93M -39.97M -75.42M -76.63M -528M -207M -2.64B -200M -196M -8.42B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
16/10/26 ₹356.70 +1.55% 15,077
15/10/26 ₹351.25 +0.59% 9,976
14/10/26 ₹349.20 +3.31% 2,878
13/10/26 ₹338.00 -1.16% 3,105
12/10/26 ₹341.95 +3.59% 2,684
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B